The ubiquitin ligase MuRF1 regulates PPARα activity in the heart by enhancing nuclear export via monoubiquitination

Molecular and Cellular Endocrinology

Volumn 413, Issue , 2015, Pages 36-48

  Rodríguez, Jessica E ^a   Liao, Jie Ying ^a   He, Jun ^b   Schisler, Jonathan C ^a   Newgard, Christopher B ^c   Drujan, Doreen ^d   Glass, David J ^d   Frederick, C Brandon ^e   Yoder, Bryan C ^e   Lalush, David S ^e   Patterson, Cam ^a,f   Willis, Monte S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NINGXIA MEDICAL UNIVERSITY   (China)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Cardiac metabolism; Cardiomyocyte; Fatty acid metabolism; Monoubiquitination; Muscle ring finger 1; Peroxisome proliferator activated receptor

Indexed keywords

ACYLCARNITINE; LYSINE; MUSCLE RING FINGER 1 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEASOME; MUSCLE PROTEIN; TRIM63 PROTEIN, MOUSE; TRIPARTITE MOTIF PROTEIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; FATTY ACID OXIDATION; HEART DISEASE; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HEART PROTECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; METABOLIC REGULATION; MOUSE; NONHUMAN; NUCLEAR EXPORT SIGNAL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; TRANSCRIPTION REGULATION; UBIQUITINATION; ACTIVE TRANSPORT; ANIMAL; CARDIAC MUSCLE; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; HEART FAILURE; MICE; MICE, KNOCKOUT; MUSCLE PROTEINS; MYOCARDIUM; PPAR ALPHA; TRIPARTITE MOTIF PROTEINS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84938207312     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.06.008     Document Type: Article

References (64)

1. Adams V., Linke A., Wisloff U., Doring C., Erbs S., Krankel N., Witt C.C., Labeit S., Muller-Werdan U., Schuler G., Hambrecht R. Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: effect on myocardial contractility. Cardiovasc. Res. 2007, 73:120-129.
2. Arya R., Kedar V., Hwang J.R., McDonough H., Li H.H., Taylor J., Patterson C. Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy. J. Cell. Biol. 2004, 167:1147-1159.
3. el Azzouzi H., Leptidis S., Bourajjaj M., van Bilsen M., da Costa Martins P.A., De Windt L.J. MEK1 inhibits cardiac PPARalpha activity by direct interaction and prevents its nuclear localization. PLoS One 2012, 7:e36799.
4. Baehr L.M., Furlow J.D., Bodine S.C. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. J. Physiol. 2011, 589:4759-4776.
5. Barger P.M., Kelly D.P. PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc. Med. 2000, 10:238-245.
6. Barger P.M., Brandt J.M., Leone T.C., Weinheimer C.J., Kelly D.P. Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. J. Clin. Invest. 2000, 105:1723-1730.
7. Baskin K.K., Taegtmeyer H. AMP-activated protein kinase regulates E3 ligases in rodent heart. Circ. Res. 2011, 109:1153-1161.
8. van Bilsen M., Smeets P.J., Gilde A.J., van der Vusse G.J. Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?. Cardiovasc. Res. 2004, 61:218-226.
9. Blanquart C., Barbier O., Fruchart J.C., Staels B., Glineur C. Peroxisome proliferator-activated receptor alpha (PPARalpha) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes. J. Biol. Chem. 2002, 277:37254-37259.
10. Blanquart C., Mansouri R., Paumelle R., Fruchart J.C., Staels B., Glineur C. The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha. Mol. Endocrinol. 2004, 18:1906-1918.
11. Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., Poueymirou W.T., Panaro F.J., Na E., Dharmarajan K., Pan Z.Q., Valenzuela D.M., DeChiara T.M., Stitt T.N., Yancopoulos G.D., Glass D.J. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001, 294:1704-1708.
12. Borland M.G., Khozoie C., Albrecht P.P., Zhu B., Lee C., Lahoti T.S., Gonzalez F.J., Peters J.M. Stable over-expression of PPARbeta/delta and PPARgamma to examine receptor signaling in human HaCaT keratinocytes. Cell. Signal. 2011, 23:2039-2050.
13. Brown V.M., Krynetski E.Y., Krynetskaia N.F., Grieger D., Mukatira S.T., Murti K.G., Slaughter C.A., Park H.W., Evans W.E. A novel CRM1-mediated nuclear export signal governs nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase following genotoxic stress. J. Biol. Chem. 2004, 279:5984-5992.
14. Burgermeister E., Seger R. MAPK kinases as nucleo-cytoplasmic shuttles for PPARgamma. Cell. Cycle 2007, 6:1539-1548.
15. Burkhoff D., Weiss R.G., Schulman S.P., Kalil-Filho R., Wannenburg T., Gerstenblith G. Influence of metabolic substrate on rat heart function and metabolism at different coronary flows. Am. J. Physiol. 1991, 261:H741-H750.
16. Carter S., Bischof O., Dejean A., Vousden K.H. C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat. Cell. Biol. 2007, 9:428-435.
17. Chen C., Krausz K.W., Shah Y.M., Idle J.R., Gonzalez F.J. Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity. Chem. Res. Toxicol. 2009, 22:699-707.
18. la Cour T., Kiemer L., Molgaard A., Gupta R., Skriver K., Brunak S. Analysis and prediction of leucine-rich nuclear export signals. Protein Eng. Des. Sel. 2004, 17:527-536.
19. Doenst T., Nguyen T.D., Abel E.D. Cardiac metabolism in heart failure: implications beyond ATP production. Circ. Res. 2013, 113:709-724.
20. Dowell P., Ishmael J.E., Avram D., Peterson V.J., Nevrivy D.J., Leid M. Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein. J. Biol. Chem. 1999, 274:15901-15907.
21. Durchschlag E., Reiter W., Ammerer G., Schuller C. Nuclear localization destabilizes the stress-regulated transcription factor Msn2. J. Biol. Chem. 2004, 279:55425-55432.
22. Escher P., Braissant O., Basu-Modak S., Michalik L., Wahli W., Desvergne B. Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 2001, 142:4195-4202.
23. Li M., Brooks C.L., Wu-Baer F., Chen D., Baer R., Gu W. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 2003, 302:1972-1975.
24. Li H.H., Du J., Fan Y.N., Zhang M.L., Liu D.P., Li L., Lockyer P., Kang E.Y., Patterson C., Willis M.S. The ubiquitin ligase MuRF1 protects against cardiac ischemia/reperfusion injury by its proteasome-dependent degradation of phospho-c-Jun. Am. J. Pathol. 2011, 178:1043-1058.
25. Fan Y., Guo Y., Hamblin M., Chang L., Zhang J., Chen Y.E. Inhibition of gluconeogenic genes by calcium-regulated heat-stable protein 1 via repression of peroxisome proliferator-activated receptor alpha. J. Biol. Chem. 2011, 286:40584-40594.
26. Fielitz J., Kim M.S., Shelton J.M., Latif S., Spencer J.A., Glass D.J., Richardson J.A., Bassel-Duby R., Olson E.N. Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3. J. Clin. Invest. 2007, 117:2486-2495.
27. Flores A.M., Gurevich I., Zhang C., Ramirez V.P., Devens T.R., Aneskievich B.J. TNIP1 is a corepressor of agonist-bound PPARs. Arch. Biochem. Biophys. 2011, 516:58-66.
28. Gareau J.R., Lima C.D. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell. Biol. 2010, 11:861-871.
29. Gopinathan L., Hannon D.B., Peters J.M., Vanden Heuvel J.P. Regulation of peroxisome proliferator-activated receptor-alpha by MDM2. Toxicol. Sci. 2009, 108:48-58.
30. Haglund K., Sigismund S., Polo S., Szymkiewicz I., Di Fiore P.P., Dikic I. Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation. Nat. Cell. Biol. 2003, 5:461-466.
31. Hake S.B., Masternak K., Kammerbauer C., Janzen C., Reith W., Steimle V. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation. Mol. Cell. Biol. 2000, 20:7716-7725.
32. Hirotani M., Tsukamoto T., Bourdeaux J., Sadano H., Osumi T. Stabilization of peroxisome proliferator-activated receptor alpha by the ligand. Biochem. Biophys. Res. Commun. 2001, 288:106-110.
33. Kedar V., McDonough H., Arya R., Li H.H., Rockman H.A., Patterson C. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:18135-18140.
34. Kim H.T., Kim K.P., Lledias F., Kisselev A.F., Scaglione K.M., Skowyra D., Gygi S.P., Goldberg A.L. Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J. Biol. Chem. 2007, 282:17375-17386.
35. Kolwicz S.C., Purohit S., Tian R. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ. Res. 2013, 113:603-616.
36. Korvald C., Elvenes O.P., Myrmel T. Myocardial substrate metabolism influences left ventricular energetics in vivo. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H1345-H1351.
37. Kota B.P., Huang T.H., Roufogalis B.D. An overview on biological mechanisms of PPARs. Pharmacol. Res. 2005, 51:85-94.
38. Kudo N., Wolff B., Sekimoto T., Schreiner E.P., Yoneda Y., Yanagida M., Horinouchi S., Yoshida M. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell. Res. 1998, 242:540-547.
39. Kudo N., Matsumori N., Taoka H., Fujiwara D., Schreiner E.P., Wolff B., Yoshida M., Horinouchi S. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:9112-9117.
40. Laghezza A., Pochetti G., Lavecchia A., Fracchiolla G., Faliti S., Piemontese L., Di Giovanni C., Iacobazzi V., Infantino V., Montanari R., Capelli D., Tortorella P., Loiodice F. New 2-(aryloxy)-3-phenylpropanoic acids as peroxisome proliferator-activated receptor alpha/gamma dual agonists able to upregulate mitochondrial carnitine shuttle system gene expression. J. Med. Chem. 2013, 56:60-72.
41. Lee J.T., Wheeler T.C., Li L., Chin L.S. Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death. Hum. Mol. Genet. 2008, 17:906-917.
42. Lehman J.J., Kelly D.P. Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth. Heart Fail. Rev. 2002, 7:175-185.
43. Lin R., Yang L., Arguello M., Penafuerte C., Hiscott J. A CRM1-dependent nuclear export pathway is involved in the regulation of IRF-5 subcellular localization. J. Biol. Chem. 2005, 280:3088-3095.
44. Liu X., Subramani S. Unique requirements for mono- and polyubiquitination of the peroxisomal targeting signal co-receptor, Pex20. J. Biol. Chem. 2013, 288:7230-7240.
45. Madrazo J.A., Kelly D.P. The PPAR trio: regulators of myocardial energy metabolism in health and disease. J. Mol. Cell. Cardiol. 2008, 44:968-975.
46. Makowski L., Noland R.C., Koves T.R., Xing W., Ilkayeva O.R., Muehlbauer M.J., Stevens R.D., Muoio D.M. Metabolic profiling of PPARalpha-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation. FASEB J. 2009, 23:586-604.
47. Mattox T.A., Young M.E., Rubel C.E., Spaniel C., Rodriguez J.E., Grevengoed T.J., Gautel M., Xu Z., Anderson E.J., Willis M.S. MuRF1 activity is present in cardiac mitochondria and regulates reactive oxygen species production in vivo. J. Bioenerg. Biomembr. 2014, 46:173-187.
48. Mearini G., Gedicke C., Schlossarek S., Witt C.C., Kramer E., Cao P., Gomes M.D., Lecker S.H., Labeit S., Willis M.S., Eschenhagen T., Carrier L. Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms. Cardiovasc. Res. 2010, 85:357-366.
49. Michalik L., Auwerx J., Berger J.P., Chatterjee V.K., Glass C.K., Gonzalez F.J., Grimaldi P.A., Kadowaki T., Lazar M.A., O'Rahilly S., Palmer C.N., Plutzky J., Reddy J.K., Spiegelman B.M., Staels B., Wahli W. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol. Rev. 2006, 58:726-741.
50. Morgan E.E., Chandler M.P., Young M.E., McElfresh T.A., Kung T.A., Rennison J.H., Tserng K.Y., Hoit B.D., Stanley W.C. Dissociation between gene and protein expression of metabolic enzymes in a rodent model of heart failure. Eur. J. Heart Fail. 2006, 8:687-693.
51. Morgan E.E., Rennison J.H., Young M.E., McElfresh T.A., Kung T.A., Tserng K.Y., Hoit B.D., Stanley W.C., Chandler M.P. Effects of chronic activation of peroxisome proliferator-activated receptor-alpha or high-fat feeding in a rat infarct model of heart failure. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H1899-H1904.
52. Paul A., Schinke M., Brown J., Riggi L.E., Izumo S., Bartunek J., Allen P., Tsubakihara M. Changes in cardiac transcription profiles brought about by heart failure. Bauer Center for Genomic Research 2004, NCBI, Gene Expression Omnibus, Cardiac transcription profiles of myocardial samples from patients undergoing cardiac transplantation whose failure arises from different etiologies (e.g. idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, alcoholic cardiomyopathy, valvular cardiomyopathy, and hypertrophic cardiomyopathy) and from "normal" organ donors whose hearts cannot be used for transplants. H.U. Cardiogenomics (Ed.).
53. Pellieux C., Aasum E., Larsen T.S., Montessuit C., Papageorgiou I., Pedrazzini T., Lerch R. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway. J. Mol. Cell. Cardiol. 2006, 41:459-466.
54. Sadowski M., Suryadinata R., Tan A.R., Roesley S.N., Sarcevic B. Protein monoubiquitination and polyubiquitination generate structural diversity to control distinct biological processes. IUBMB Life 2012, 64:136-142.
55. Simon-Areces J., Acaz-Fonseca E., Ruiz-Palmero I., Garcia-Segura L.M., Arevalo M.A. A CRM1-mediated nuclear export signal is essential for cytoplasmic localization of neurogenin 3 in neurons. PLoS One 2013, 8:e55237.
56. Trotman L.C., Wang X., Alimonti A., Chen Z., Teruya-Feldstein J., Yang H., Pavletich N.P., Carver B.S., Cordon-Cardo C., Erdjument-Bromage H., Tempst P., Chi S.G., Kim H.J., Misteli T., Jiang X., Pandolfi P.P. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 2007, 128:141-156.
57. Turer A.T., Stevens R.D., Bain J.R., Muehlbauer M.J., van der Westhuizen J., Mathew J.P., Schwinn D.A., Glower D.D., Newgard C.B., Podgoreanu M.V. Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. Circulation 2009, 119:1736-1746.
58. Wadosky K.M., Willis M.S. The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:H515-H526.
59. Wadosky K.M., Rodriguez J.E., Hite R.L., Min J.N., Walton B.L., Willis M.S. Muscle RING finger-1 attenuates IGF-I-dependent cardiomyocyte hypertrophy by inhibiting JNK signaling. Am. J. Physiol. Endocrinol. Metab. 2014, 306:E723-E739.
60. Willis M.S., Ike C., Li L., Wang D.Z., Glass D.J., Patterson C. Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo. Circ. Res. 2007, 100:456-459.
61. Willis M.S., Rojas M., Li L., Selzman C.H., Tang R.H., Stansfield W.E., Rodriguez J.E., Glass D.J., Patterson C. Muscle ring finger 1 mediates cardiac atrophy in vivo. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H997-H1006.
62. Willis M.S., Schisler J.C., Li L., Rodriguez J.E., Hilliard E.G., Charles P.C., Patterson C. Cardiac muscle ring finger-1 increases susceptibility to heart failure in vivo. Circ. Res. 2009, 105:80-88.
63. Witt S.H., Granzier H., Witt C.C., Labeit S. MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination. J. Mol. Biol. 2005, 350:713-722.
64. Zhao G., Jeoung N.H., Burgess S.C., Rosaaen-Stowe K.A., Inagaki T., Latif S., Shelton J.M., McAnally J., Bassel-Duby R., Harris R.A., Richardson J.A., Kliewer S.A. Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H936-H943.